NM_001378452.1:c.7054C>T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001378452.1(ITPR1):​c.7054C>T​(p.Leu2352Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.283 in 1,613,528 control chromosomes in the GnomAD database, including 66,485 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 5109 hom., cov: 32)
Exomes 𝑓: 0.29 ( 61376 hom. )

Consequence

ITPR1
NM_001378452.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.0270

Publications

24 publications found
Variant links:
Genes affected
ITPR1 (HGNC:6180): (inositol 1,4,5-trisphosphate receptor type 1) This gene encodes an intracellular receptor for inositol 1,4,5-trisphosphate. Upon stimulation by inositol 1,4,5-trisphosphate, this receptor mediates calcium release from the endoplasmic reticulum. Mutations in this gene cause spinocerebellar ataxia type 15, a disease associated with an heterogeneous group of cerebellar disorders. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]
ITPR1 Gene-Disease associations (from GenCC):
  • aniridia-cerebellar ataxia-intellectual disability syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • spinocerebellar ataxia type 29
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet
  • spinocerebellar ataxia type 15/16
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 3-4800547-C-T is Benign according to our data. Variant chr3-4800547-C-T is described in CliVar as Benign. Clinvar id is 129302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-4800547-C-T is described in CliVar as Benign. Clinvar id is 129302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-4800547-C-T is described in CliVar as Benign. Clinvar id is 129302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-4800547-C-T is described in CliVar as Benign. Clinvar id is 129302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-4800547-C-T is described in CliVar as Benign. Clinvar id is 129302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-4800547-C-T is described in CliVar as Benign. Clinvar id is 129302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-4800547-C-T is described in CliVar as Benign. Clinvar id is 129302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-4800547-C-T is described in CliVar as Benign. Clinvar id is 129302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-4800547-C-T is described in CliVar as Benign. Clinvar id is 129302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-4800547-C-T is described in CliVar as Benign. Clinvar id is 129302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-4800547-C-T is described in CliVar as Benign. Clinvar id is 129302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-4800547-C-T is described in CliVar as Benign. Clinvar id is 129302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-4800547-C-T is described in CliVar as Benign. Clinvar id is 129302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-4800547-C-T is described in CliVar as Benign. Clinvar id is 129302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-4800547-C-T is described in CliVar as Benign. Clinvar id is 129302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-4800547-C-T is described in CliVar as Benign. Clinvar id is 129302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-4800547-C-T is described in CliVar as Benign. Clinvar id is 129302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-4800547-C-T is described in CliVar as Benign. Clinvar id is 129302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.027 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.375 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITPR1NM_001378452.1 linkc.7054C>T p.Leu2352Leu synonymous_variant Exon 54 of 62 ENST00000649015.2 NP_001365381.1
ITPR1NM_001168272.2 linkc.7009C>T p.Leu2337Leu synonymous_variant Exon 53 of 61 NP_001161744.1 Q14643-2
ITPR1NM_001099952.4 linkc.6910C>T p.Leu2304Leu synonymous_variant Exon 51 of 59 NP_001093422.2 Q14643-3B4DER3Q59H91
ITPR1NM_002222.7 linkc.6865C>T p.Leu2289Leu synonymous_variant Exon 50 of 58 NP_002213.5 Q14643-4B4DER3B4DGH1Q59H91

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITPR1ENST00000649015.2 linkc.7054C>T p.Leu2352Leu synonymous_variant Exon 54 of 62 NM_001378452.1 ENSP00000497605.1 Q14643-1
ITPR1ENST00000354582.12 linkc.7030C>T p.Leu2344Leu synonymous_variant Exon 54 of 62 5 ENSP00000346595.8 A0A3F2YNW8
ITPR1ENST00000648266.1 linkc.7027C>T p.Leu2343Leu synonymous_variant Exon 54 of 62 ENSP00000498014.1 A0A3B3IU04
ITPR1ENST00000650294.1 linkc.7012C>T p.Leu2338Leu synonymous_variant Exon 53 of 61 ENSP00000498056.1 A0A3B3ITU8
ITPR1ENST00000443694.5 linkc.7009C>T p.Leu2337Leu synonymous_variant Exon 53 of 61 1 ENSP00000401671.2 Q14643-2
ITPR1ENST00000648309.1 linkc.6982C>T p.Leu2328Leu synonymous_variant Exon 51 of 59 ENSP00000497026.1 Q14643-5
ITPR1ENST00000357086.10 linkc.6910C>T p.Leu2304Leu synonymous_variant Exon 51 of 59 1 ENSP00000349597.4 Q14643-3
ITPR1ENST00000456211.8 linkc.6865C>T p.Leu2289Leu synonymous_variant Exon 50 of 58 1 ENSP00000397885.2 Q14643-4
ITPR1ENST00000648038.1 linkc.4816C>T p.Leu1606Leu synonymous_variant Exon 34 of 42 ENSP00000497872.1 A0A3B3ITQ1
ITPR1ENST00000648431.1 linkc.4231C>T p.Leu1411Leu synonymous_variant Exon 31 of 39 ENSP00000498149.1 A0A3B3IU05
ITPR1ENST00000648212.1 linkc.3994C>T p.Leu1332Leu synonymous_variant Exon 31 of 39 ENSP00000498022.1 A0A3B3IU13

Frequencies

GnomAD3 genomes
AF:
0.249
AC:
37797
AN:
152088
Hom.:
5099
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.140
Gnomad AMI
AF:
0.291
Gnomad AMR
AF:
0.316
Gnomad ASJ
AF:
0.325
Gnomad EAS
AF:
0.389
Gnomad SAS
AF:
0.281
Gnomad FIN
AF:
0.238
Gnomad MID
AF:
0.275
Gnomad NFE
AF:
0.283
Gnomad OTH
AF:
0.273
GnomAD2 exomes
AF:
0.293
AC:
73061
AN:
249164
AF XY:
0.292
show subpopulations
Gnomad AFR exome
AF:
0.132
Gnomad AMR exome
AF:
0.370
Gnomad ASJ exome
AF:
0.327
Gnomad EAS exome
AF:
0.413
Gnomad FIN exome
AF:
0.231
Gnomad NFE exome
AF:
0.283
Gnomad OTH exome
AF:
0.288
GnomAD4 exome
AF:
0.286
AC:
418458
AN:
1461322
Hom.:
61376
Cov.:
35
AF XY:
0.286
AC XY:
208252
AN XY:
726968
show subpopulations
African (AFR)
AF:
0.127
AC:
4253
AN:
33472
American (AMR)
AF:
0.364
AC:
16279
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.324
AC:
8464
AN:
26134
East Asian (EAS)
AF:
0.405
AC:
16088
AN:
39692
South Asian (SAS)
AF:
0.296
AC:
25496
AN:
86224
European-Finnish (FIN)
AF:
0.229
AC:
12249
AN:
53400
Middle Eastern (MID)
AF:
0.346
AC:
1993
AN:
5766
European-Non Finnish (NFE)
AF:
0.285
AC:
316597
AN:
1111568
Other (OTH)
AF:
0.282
AC:
17039
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
16196
32392
48589
64785
80981
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10608
21216
31824
42432
53040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.249
AC:
37856
AN:
152206
Hom.:
5109
Cov.:
32
AF XY:
0.249
AC XY:
18493
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.141
AC:
5853
AN:
41542
American (AMR)
AF:
0.316
AC:
4837
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.325
AC:
1129
AN:
3472
East Asian (EAS)
AF:
0.389
AC:
2012
AN:
5176
South Asian (SAS)
AF:
0.282
AC:
1363
AN:
4828
European-Finnish (FIN)
AF:
0.238
AC:
2522
AN:
10590
Middle Eastern (MID)
AF:
0.289
AC:
85
AN:
294
European-Non Finnish (NFE)
AF:
0.282
AC:
19204
AN:
67988
Other (OTH)
AF:
0.278
AC:
587
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1468
2936
4403
5871
7339
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
404
808
1212
1616
2020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.272
Hom.:
12830
Bravo
AF:
0.252
Asia WGS
AF:
0.306
AC:
1068
AN:
3478
EpiCase
AF:
0.294
EpiControl
AF:
0.293

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 04, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Jul 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Gillespie syndrome Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant cerebellar ataxia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Spinocerebellar ataxia type 29 Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spinocerebellar ataxia type 15/16 Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
0.45
DANN
Benign
0.57
PhyloP100
0.027
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2291862; hg19: chr3-4842231; COSMIC: COSV56973948; API